Expanding Glucagon Access and Use in the Prehospital Setting - JEMS: EMS, Emergency Medical Services - Training, Paramedic, EMT News
Using the New Gvoke HypoPen: Glucagon Product Review
Preparing and Using a Glucagon Emergency Kit – Resus Review
GLUCAGON AGENTS; Current Product Listing. LABEL NAME GENERIC NAME MANUFACTURER DRUG TYPE PROVIDER SYNERGIES BRAND NAME ROUTE BAQ
Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia
G-pen may aid hypoglycemia with type 1 diabetes
Harnessing Hypos: Glucagon As An Everyday Tool | Insulin Nation
Xeris' glucagon injection Gvoke gains heat with HypoPen auto-injector launch | Fierce Pharma
Prescribing Information for Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors (Based on US Labels) | Radcliffe Cardiology
Fresenius Kabi Introduces Glucagon Emergency Medicine Kit to Treat Life-Threatening Episodes of Low Blood Sugar - Fresenius Kabi USA
Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar
Glucagon
Glucagon for hypoglycaemia treatment in type 1 diabetes - Ranjan - 2021 - Diabetes/Metabolism Research and Reviews - Wiley Online Library
Gvoke HydoPen Glucagon Injection 1 mg Per 0.2 mL Autoinjector — Mountainside Medical Equipment
Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation | Diabetes Technology & Therapeutics
GVOKE (glucagon injection) Xeris Pharmaceuticals, Inc. These highlights do not include all the information needed to use GVOKE safely and effectively. See full prescribing information for GVOKE. GVOKE (glucagon injection), for subcutaneous
Glucagon Options for People with Diabetes - Children with Diabetes
FDA Approves First Ready-to-Use Glucagon Pen - Diabetic Nation
Harnessing Hypos: Glucagon As An Everyday Tool | Insulin Nation
Diabetic? Here's Why You Need a Glucagon Pen
Glucagon
Company name and structure
Xeris Doses First Patient in Phase 2 Study of Mini-dose Glucagon for mild-moderate hypoglycemia in T1D patients
